Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis

Overview of attention for article published in Nature Genetics, July 1994

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

policy: 1 policy source

patent: 78 patents

Readers on

mendeley: 50 Mendeley

So far, Altmetric has seen 78 patents that reference this research output.

DNA sequence modification-based gene drive

Grant US-12577583-B2

United States of America

17 Mar 2026

Population control using engineered translocations

Grant US-12213468-B2

United States of America

04 Feb 2025

METHOD OF DIAGNOSING VASOREGULATORY DISORDERS

Application WO-2020053808-A1

World Intellectual Property Organisation (WIPO)

19 Mar 2020

Antibody-mediated immunocontraception

Grant US-10570200-B2

United States of America

25 Feb 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 74 additional patents.